Singapore, 27 July 2026 – Raffles Medical Group recorded a 9.6% decline in net profit to S$29 million for the first half of 2026 as lower occupancy at transitional-care facilities outweighed improving hospital earnings, stronger China revenue and a reduced insurance loss.

The Singapore-listed healthcare provider’s profit fell from S$32.1 million during the corresponding period of 2025. Diluted earnings per share declined to 1.57 Singapore cents from 1.73 cents previously.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

Author

Rebecca Hsu

Rebecca Hsu is a Senior Economist and Lead Analyst for The Ledger Asia, focusing on the rapidly evolving financial landscapes of East and Southeast Asia. With a background in sovereign risk assessment and emerging market trends, Rebecca provides sharp commentary on trade dynamics, monetary policy, and the digital economy's impact on regional growth.

Formerly a strategic advisor for major financial institutions in Hong Kong, she excels at translating complex macroeconomic shifts into actionable insights for investors and policymakers. Her work at The Ledger Asia centers on China’s economic transition and the burgeoning manufacturing hubs of ASEAN, ensuring readers stay ahead of Asia’s shifting financial tides.

Raffles Medical H1 Profit Falls 9.6% as Healthcare Revenue Weakens

Unlock the Full Article

Author

Share this:

Related